Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats

Molecular Pain

Volumn 7, Issue , 2011, Pages

  De Filippis, Daniele ^a,c   Luongo, Livio ^b,c   Cipriano, Mariateresa ^a,c   Palazzo, Enza ^b,c   Cinelli, Maria Pia ^a   de Novellis, Vito ^a   Maione, Sabatino ^b,c   Iuvone, Teresa ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Endocannabinoid Research Group   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PALMIDROL; CARRAGEENAN; PALMITIC ACID DERIVATIVE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; HYPERALGESIA; MALE; MAST CELL; MAST CELL DEGRANULATION; NERVE FIBER; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; ANIMAL; DRUG EFFECT; GRANULOMA; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; TIME; WISTAR RAT;

ANIMALS; CARRAGEENAN; GANGLIA, SPINAL; GRANULOMA; HYPERALGESIA; MALE; MAST CELLS; NERVE FIBERS; NERVE GROWTH FACTORS; NEUROGENESIS; PALMITIC ACIDS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 78650972394     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-3     Document Type: Article

References (44)

1. De Filippis D, D'Amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 2008, 1(Suppl 20):20-5. Review..
2. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132:26-37. 10.1053/j.gastro.2006.11.039, 17241857.
3. Cyphert JM, Kovarova M, Allen IC, Hartney JM, Murphy DL, Wess J, Koller BH. Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction. J Immunol 2009, 182:7430-9. 10.4049/jimmunol.0900039, 19494266.
4. Mori N, Suzuki R, Furuno T, McKay DM, Wada M, Teshima R, Bienenstock J, Nakanishi M. () Nerve-mast cell (RBL) interaction: RBL membrane ruffling occurs at the contact site with an activated neurite. Am J Physiol Cell Physiol 2002, 283:C1738-44.
5. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992, 49:693-8. 10.1016/0306-4522(92)90237-V, 1380138.
6. Nienartowicz A, Sobaniec-Łotowska ME, Jarocka-Cyrta E, Lemancewicz D. Mast cells in neoangiogenesis. Med Sci Monit 2006, 12:RA53-6. Review..
7. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci 1994, 91:3739-43. 10.1073/pnas.91.9.3739, 43657, 8170980.
8. Levi-Montalcini R. Update of the NGF saga. J Neurol Sci 1995, 30:119-27.
9. Peters EM. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 2006, 126:1937-47. 10.1038/sj.jid.5700429, 16912691.
10. Groneberg DA, Serowka F, Peckenschneider N, Artuc M, Grützkau A, Fischer A, Henz BM, Welker P. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 2005, 161:87-92. 10.1016/j.jneuroim.2004.12.019, 15748947.
11. Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, Adachi R, Gurish MF, Gobezie R, Stevens RL, Lee DM. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 2009, 182:647-56. 2610352, 19109198.
12. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992, 35:351-5. 10.1002/art.1780350315, 1536673.
13. Andreev N, Dimitrieva N, Koltzenburg M, McMahon SB. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain 1995, 63:109-15. 10.1016/0304-3959(95)00024-M, 8577480.
14. McMahon SB, Bennett DL, Priestley JV, Shelton DL. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995, 1:774-80. 10.1038/nm0895-774, 7585179.
15. Schnegelsberg B, Sun TT, Cain G, Bhattacharya A, Nunn PA, Ford AP, Vizzard MA, Cockayne DA. Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol 2010, 298:R534-47.
16. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998, 394:277-81. 10.1038/28393, 9685157.
17. Brown A, Ricci MJ, Weaver LC. NGF message and protein distribution in the injured rat spinal cord. Exp Neurol 2004, 188:115-27. 10.1016/j.expneurol.2004.03.017, 15191808.
18. Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, Shelton DL, Davies AM. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 2006, 27:85-91. 10.1016/j.tips.2005.12.001, 16376998.
19. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995, 92:3376-80. 10.1073/pnas.92.8.3376, 42169, 7724569.
20. Cerrato S. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFα release from canine skin mast cells. Vet Immunol Immunopathol 2010, 133:9-15. 10.1016/j.vetimm.2009.06.011, 19625089.
21. De Filippis D, D'Amico A, Cipriano M, Petrosino S, Orlando P, Di Marzo V, Iuvone T. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol Res 2010, 61:321-8. 10.1016/j.phrs.2009.11.005, 19931394.
22. Ambrosini A, Zolese G, Ambrosi S, Bertoli E, Mantero F, Boscaro M, Balercia G. Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. J Androl 2005, 26:429-36. 10.2164/jandrol.04141, 15867012.
23. De Filippis D, D'Amico A, Cinelli MP, Esposito G, Di Marzo V, Iuvone T. Adelmidrol, a Palmitoylethanolamide analog, reduces chronic inflammation in a carrageenin-granuloma model in rats. J Cell Mol Med 2009, 13:1086-95. 10.1111/j.1582-4934.2008.00353.x, 18429935.
24. Tóth ZE, Mezey E. Simultaneous visualization of multiple antigens with tyramide signal amplification using antibodies from the same species. J Histochem Cytochem 2007, 55:545-54.
25. Miyamoto T, Dubin AE, Petrus MJ, Patapoutian A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One 2009, 4:e7596. 10.1371/journal.pone.0007596, 2764051, 19893614.
26. Skaper. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets 2008, 7:46-62. Review., 10.2174/187152708783885174, 18289031.
27. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993, 13:2136-48.
28. Bonnington JK, McNaughton PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 2003, 551:433-46. 10.1113/jphysiol.2003.039990, 2343223, 12815188.
29. Xue Q, Jong B, Chen T, Schumacher MA. Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem 2007, 101(1):212-22. 10.1111/j.1471-4159.2006.04363.x, 17217411.
30. Tore F, Tuncel N. Mast cells: target and source of neuropeptides. Curr Pharm Des 2009, 15:3433-45. 10.2174/138161209789105036, 19860689.
31. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007, 105:838-47. 10.1213/01.ane.0000275190.42912.37, 17717248.
32. Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPAR-γ receptors and neurotrophic factors. Pain 2008, 139:541-50. 10.1016/j.pain.2008.06.003, 18602217.
33. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 2010, 62:588-631. 10.1124/pr.110.003004, 21079038.
34. Rukwied R, Mayer A, Kluschina O, Obreja O, Schley M, Schmelz M. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain 2010, 148:407-413. 10.1016/j.pain.2009.11.022, 20022698.
35. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006, 29:507-38. Review., 10.1146/annurev.neuro.29.051605.112929, 16776595.
36. Mendell LM, Albers KM, Davis BM. Neurotrophins, nociceptors, and pain. Microsc Res Tech 1999, 45:252-61. Review., 10.1002/(SICI)1097-0029(19990515/01)45:4/5<252::AID-JEMT9>3.0.CO;2-N, 10383118.
37. Ständer S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008, 17:161-9.
38. Calignano A, La Rana G, Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 2001, 419:191-8. 10.1016/S0014-2999(01)00988-8, 11426841.
39. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A. N-(2- hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996, 300:227-36. 10.1016/0014-2999(96)00015-5, 8739213.
40. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, Mattace Raso G, Cuzzocrea S, Loverme J, Piomelli D, Meli R, Calignano A. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kB nuclear signalling in dorsal root ganglia. Eur J Pharmacol 2009, 613:54-9.
41. Schaeffer V, Meyer L, Patte-Mensah C, Eckert A, Mensah-Nyagan AG. Sciatic nerve injury induces apoptosis of dorsal root ganglion satellite glial cells and selectively modifies neurosteroidogenesis in sensory neurons. Glia 2010, 58:169-80. 10.1002/glia.20910, 19565659.
42. Hoheisel U, Unger T, Mense S. Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivo. Brain Res 2007, 1169:34-43. 10.1016/j.brainres.2007.06.054, 17698048.
43. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 2006, 319:1051-61. 10.1124/jpet.106.111385, 16997973.
44. Re G, Barbero R, Miolo A, Di Marzo V. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet J 2007, 173:21-30. Review., 10.1016/j.tvjl.2005.10.003, 16324856.